Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.
2.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
3.

Management of atrial fibrillation in the elderly.

Aronow WS.

Minerva Med. 2009 Feb;100(1):3-24. Epub 2009 Jan 30. Review.

PMID:
19182738
4.

Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.

Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.

Card Electrophysiol Rev. 2003 Sep;7(3):201-7. Review.

PMID:
14739713
5.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

6.

Current management of symptomatic atrial fibrillation.

Haghi D, Schumacher B.

Am J Cardiovasc Drugs. 2001;1(2):127-39. Review.

PMID:
14728042
7.

Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.

Bhatia GS, Lip GY.

Curr Heart Fail Rep. 2004 Dec;1(4):149-55. Review.

PMID:
16036038
8.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
9.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
10.

The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.

Mayson SE, Greenspon AJ, Adams S, Decaro MV, Sheth M, Weitz HH, Whellan DJ.

Cardiol Rev. 2007 Sep-Oct;15(5):231-41. Review.

PMID:
17700382
11.

Pharmacological approaches in the treatment of atrial fibrillation.

Tamargo J, Caballero R, Delp├│n E.

Curr Med Chem. 2004 Jan;11(1):13-28. Review.

PMID:
14754423
12.

Novel approaches for pharmacological management of atrial fibrillation.

Ehrlich JR, Nattel S.

Drugs. 2009;69(7):757-74. doi: 10.2165/00003495-200969070-00001. Review.

PMID:
19441867
13.

Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.

Garcia D, Cheng-Lai A.

Cardiol Rev. 2009 Sep-Oct;17(5):230-4. doi: 10.1097/CRD.0b013e3181b15ab9. Review.

PMID:
19690474
14.
15.

Atrial arrhythmias after cardiac surgery in patients with diabetes mellitus.

Jung W, Meyerfeldt U, Birkemeyer R.

Clin Res Cardiol. 2006 Jan;95 Suppl 1:i88-97. Review.

PMID:
16598557
16.

[Antiarrhythmic drugs in atrial fibrillation].

Brembilla-Perrot B.

Rev Prat. 2002 Jun 15;52(12):1317-23. Review. French.

PMID:
12187895
17.

Proarrhythmia.

Friedman PL, Stevenson WG.

Am J Cardiol. 1998 Oct 16;82(8A):50N-58N. Review.

PMID:
9809901
19.

Antiarrhythmic agents and proarrhythmia.

Chaudhry GM, Haffajee CI.

Crit Care Med. 2000 Oct;28(10 Suppl):N158-64. Review.

PMID:
11055685
20.

Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.

Cairns JA.

Int J Clin Pract. 1998 Sep;52(6):422-4. Review.

PMID:
9894381
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk